Montag & Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Sell
137,790
-3,916
-3% -$452K 0.77% 30
2025
Q4
$15M Sell
141,706
-1,974
-1% -$185K 0.69% 34
2025
Q3
$12.2M Sell
143,680
-6,323
-4% -$521K 0.56% 44
2025
Q2
$12M Sell
150,003
-10,310
-6% -$820K 0.58% 45
2025
Q1
$14.5M Sell
160,313
-4,387
-3% -$410K 0.73% 34
2024
Q4
$16.5M Sell
164,700
-13,914
-8% -$1.43M 0.78% 30
2024
Q3
$20.4M Sell
178,614
-1,081
-0.6% -$128K 0.96% 21
2024
Q2
$22.4M Buy
179,695
+7,736
+4% +$996K 1.13% 15
2024
Q1
$22.8M Buy
171,959
+2,521
+1% +$311K 1.14% 15
2023
Q4
$18.6M Buy
169,438
+653
+0.4% +$67.8K 1.04% 19
2023
Q3
$17.5M Sell
168,785
-14,268
-8% -$1.54M 1.1% 17
2023
Q2
$21.3M Buy
183,053
+102
+0.1% +$11.6K 1.31% 13
2023
Q1
$19.6M Sell
182,951
-2,829
-2% -$305K 1.28% 13
2022
Q4
$20.7M Sell
185,780
-931
-0.5% -$95.2K 1.39% 13
2022
Q3
$16.2M Sell
186,711
-9,089
-5% -$811K 1.12% 15
2022
Q2
$18M Buy
195,800
+2,927
+2% +$259K 1.16% 15
2022
Q1
$15.8M Buy
192,873
+2,098
+1% +$165K 0.84% 23
2021
Q4
$14.6M Buy
190,775
+380
+0.2% +$30.3K 0.72% 29
2021
Q3
$14.3M Buy
190,395
+16,858
+10% +$1.28M 0.77% 30
2021
Q2
$13.5M Sell
173,537
-11,002
-6% -$818K 0.72% 30
2021
Q1
$13.6M Sell
184,539
-11,338
-6% -$836K 0.76% 30
2020
Q4
$15.3M Buy
195,877
+3,054
+2% +$234K 0.94% 22
2020
Q3
$15.3M Buy
192,823
+1,864
+1% +$146K 1.23% 14
2020
Q2
$14.1M Sell
190,959
-2,502
-1% -$188K 1.23% 15
2020
Q1
$14.2M Sell
193,461
-36,877
-16% -$2.9M 1.42% 13
2019
Q4
$20M Buy
230,338
+1,993
+0.9% +$164K 1.6% 9
2019
Q3
$18.3M Buy
228,345
+12,367
+6% +$991K 1.6% 9
2019
Q2
$17.3M Buy
215,978
+12,780
+6% +$979K 1.54% 11
2019
Q1
$16.1M Sell
203,198
-14,580
-7% -$1.09M 1.5% 12
2018
Q4
$15.9M Sell
217,778
-1,194
-0.5% -$84.3K 1.71% 8
2018
Q3
$14.8M Buy
218,972
+29,839
+16% +$1.9M 1.3% 13
2018
Q2
$11M Sell
189,133
-968
-0.5% -$54.6K 1.12% 13
2018
Q1
$9.88M Sell
190,101
-2,572
-1% -$139K 1.02% 18
2017
Q4
$10.3M Sell
192,673
-3,091
-2% -$171K 1% 18
2017
Q3
$12M Sell
195,764
-10,764
-5% -$653K 1.28% 11
2017
Q2
$12.6M Sell
206,528
-5,308
-3% -$323K 1.42% 10
2017
Q1
$12.8M Sell
211,836
-5,972
-3% -$362K 1.44% 8
2016
Q4
$12.2M Buy
217,808
+40,592
+23% +$2.38M 1.45% 6
2016
Q3
$10.6M Sell
177,216
-45,771
-21% -$2.68M 1.34% 10
2016
Q2
$12.3M Sell
222,987
-6,969
-3% -$371K 1.62% 8
2016
Q1
$11.6M Buy
229,956
+15,851
+7% +$776K 1.63% 8
2015
Q4
$10.8M Sell
214,105
-3,502
-2% -$177K 1.58% 10
2015
Q3
$10.3M Sell
217,607
-23,998
-10% -$1.27M 1.6% 8
2015
Q2
$13.1M Buy
241,605
+145,279
+151% +$8.15M 1.91% 4
2015
Q1
$5.28M Buy
96,326
+13,248
+16% +$750K 0.76% 38
2014
Q4
$4.5M Buy
83,078
+7,942
+11% +$442K 0.68% 50
2014
Q3
$4.25M Buy
75,136
+190
+0.3% +$10.7K 0.7% 46
2014
Q2
$4.14M Sell
74,946
-83
-0.1% -$4.53K 0.67% 45
2014
Q1
$4.06M Buy
75,029
+6,288
+9% +$326K 0.69% 47
2013
Q4
$3.28M Sell
68,741
-37
-0.1% -$1.69K 0.56% 58
2013
Q3
$3.12M Buy
68,778
+354
+0.5% +$16.2K 0.58% 57
2013
Q2
$3.03M Buy
+68,424
New +$3.06M 0.62% 60

Other funds holding MRK

Montag & Associates's MRK Position: Q1 2026 in Review

Montag & Associates reduced its Merck (MRK) stake by 2.8% in Q1 2026, selling an estimated $452K and leaving 137,790 shares worth $16.7M. The position accounts for 0.77% of the portfolio, ranked #30.

Montag & Associates first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.8M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Montag & Associates held 137,790 shares of Merck worth $16.7M as of Q1 2026.
  • Montag & Associates sold 3,916 Merck shares in Q1 2026, an estimated $452K.
  • Merck made up 0.77% of Montag & Associates's portfolio in Q1 2026, its #30 holding.
  • Montag & Associates first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Montag & Associates's Merck position peaked at $22.8M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.